...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >20-hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries
【24h】

20-hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries

机译:20-羟基二十碳四烯酸的抑制作用减弱大鼠颈动脉球囊损伤引起的新内膜形成和血管重塑

获取原文
获取原文并翻译 | 示例
           

摘要

20-Hydroxyeicosatetraenoic acid (20-HETE) contributes to the migration and proliferation of vascular smooth muscle cells (VSMC) in vitro, but there are few studies that address its effects on vascular remodeling in vivo. The present study determined whether inhibition of 20-HETE production attenuates intimal hyperplasia (IH) and vascular remodeling after balloon injury (BI). Sprague Dawley rats underwent BI of the common carotid artery and were treated with vehicle, 1-aminobenzotriazole (ABT, 50 mg/kg i.p. once daily), or HET0016 (N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine) (2 mg/kg s.c. twice daily) for 14 days. Fourteen days after BI and treatment, the animals underwent carotid angiography, and the arteries were harvested for morphometric, enzymatic and immunohistochemical analysis. There was a 96% reduction of angiographic stenosis in the rats treated with 1-ABT. There was a 61 and 66% reduction of the intima/media area ratios in the 1-ABT and HET0016 treated rats compared with the vehicle-treated group. 20-HETE levels were elevated in BI carotid arteries, and the levels were markedly suppressed in the groups treated with 1-ABT and HET0016 (P < 0.001). Immunostaining revealed that the expression of CYP4A enzyme was markedly increased in the neointima of BI arteries, and it colocalized with the expression of smooth muscle-specific actin, indicating increased proliferation of VSMC. An increase in the expression of CYP4A and the production of 20-HETE contributes to neointimal growth in BI rat carotid arteries. Systemic administration 1-ABT or HET0016 prevents the increase in 20-HETE levels and attenuates VSMC migration and proliferation, resulting in a marked reduction in IH and vascular remodeling after endothelial injury.
机译:20-羟基己二烯四烯酸(20-HETE)在体外有助于血管平滑肌细胞(VSMC)的迁移和增殖,但很少有研究涉及其对体内血管重构的影响。本研究确定了抑制20-HETE产生是否减轻了球囊损伤后的内膜增生(IH)和血管重塑(BI)。 Sprague Dawley大鼠经历了颈总动脉的BI,并用溶媒,1-氨基苯并三唑(ABT,每天50 mg / kg ip每天一次)或HET0016(N-羟基-N'-(4-丁基-2-甲基苯基)治疗-甲form(2 mg / kg sc每天两次),持续14天。 BI和治疗后第十四天,对动物进行颈动脉造影,并收集动脉以进行形态分析,酶促和免疫组织化学分析。用1-ABT治疗的大鼠血管造影狭窄减少了96%。与媒介物治疗组相比,经1-ABT和HET0016治疗的大鼠的内膜/中膜面积比分别降低了61%和66%。 BI-颈动脉中20-HETE水平升高,而用1-ABT和HET0016治疗的组中该水平显着受到抑制(P <0.001)。免疫染色显示CYP4A酶的表达在BI动脉的新内膜中显着增加,并且与平滑肌特异性肌动蛋白的表达共定位,表明VSMC的增殖增加。 CYP4A表达的增加和20-HETE的产生有助于BI大鼠颈动脉的新内膜生长。全身性给药1-ABT或HET0016可防止20-HETE水平增加,并减弱VSMC迁移和增殖,从而导致内皮损伤后IH和血管重塑的明显降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号